Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albiruni R Abdul Razak

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
JCO Global Oncology|December 20, 2024
Elevating Cancer Care Standards Worldwide: An Analysis of Global Initiatives and ProgressAndres Wiernik, Alvaro Rogado, Deirdre O'Mahony, et al.
Cancer Treatment Reviews|December 19, 2017
Multi-agent chemotherapy in advanced soft tissue sarcoma (STS) - A systematic review and meta-analysisAlona Zer, Rebecca M Prince, Eitan Amir, et al.
Clinical Pharmacokinetics|April 30, 2021
Pharmacokinetics of Selinexor: The First-in-Class Selective Inhibitor of Nuclear ExportJustin C Bader, Albiruni R Abdul Razak, Sharon Shacham, et al.
Molecular Oncology|August 28, 2014
Early phase clinical trials to identify optimal dosing and safetyNatalie Cook, Aaron R Hansen, Lillian L Siu, et al.
Targeted Oncology|October 5, 2022
Do Early Phase Oncology Trials Predict Clinical Efficacy in Subsequent Biomarker-Enriched Phase III Randomized Trials?Suji Udayakumar, Sasha Thomson, Albiruni R Abdul Razak, et al.
Cancer|September 18, 2024
Clinical benefit and fragility evaluation of systemic therapy trials for advanced soft tissue sarcomaDina Braik, Christopher Lemieux, Brooke E Wilson, et al.
Cancer Discovery|April 3, 2021
The Future of Clinical Trial Design in OncologyAnna Spreafico, Aaron R Hansen, Albiruni R Abdul Razak, et al.
Investigational New Drugs|May 5, 2015
Pharmacokinetic assessment of dacomitinib (pan-HER tyrosine kinase inhibitor) in patients with locally advanced head and neck squamous cell carcinoma (LA SCCHN) following administration through a gastrostomy feeding tube (GT)Joanne W Chiu, Kelvin Chan, Eric X Chen, et al.
Cancer Discovery|April 19, 2014
Promising SINEs for embargoing nuclear-cytoplasmic export as an anticancer strategyDavid S P Tan, Philippe L Bedard, John Kuruvilla, et al.
BMC Cancer|January 21, 2016
Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort studyFernando A Angarita, Amanda J Cannell, Albiruni R Abdul Razak, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
JCO Global Oncology|December 20, 2024
Elevating Cancer Care Standards Worldwide: An Analysis of Global Initiatives and ProgressAndres Wiernik, Alvaro Rogado, Deirdre O'Mahony, et al.
Cancer Treatment Reviews|December 19, 2017
Multi-agent chemotherapy in advanced soft tissue sarcoma (STS) - A systematic review and meta-analysisAlona Zer, Rebecca M Prince, Eitan Amir, et al.
Clinical Pharmacokinetics|April 30, 2021
Pharmacokinetics of Selinexor: The First-in-Class Selective Inhibitor of Nuclear ExportJustin C Bader, Albiruni R Abdul Razak, Sharon Shacham, et al.
Molecular Oncology|August 28, 2014
Early phase clinical trials to identify optimal dosing and safetyNatalie Cook, Aaron R Hansen, Lillian L Siu, et al.
Targeted Oncology|October 5, 2022
Do Early Phase Oncology Trials Predict Clinical Efficacy in Subsequent Biomarker-Enriched Phase III Randomized Trials?Suji Udayakumar, Sasha Thomson, Albiruni R Abdul Razak, et al.
Cancer|September 18, 2024
Clinical benefit and fragility evaluation of systemic therapy trials for advanced soft tissue sarcomaDina Braik, Christopher Lemieux, Brooke E Wilson, et al.
Cancer Discovery|April 3, 2021
The Future of Clinical Trial Design in OncologyAnna Spreafico, Aaron R Hansen, Albiruni R Abdul Razak, et al.
Investigational New Drugs|May 5, 2015
Pharmacokinetic assessment of dacomitinib (pan-HER tyrosine kinase inhibitor) in patients with locally advanced head and neck squamous cell carcinoma (LA SCCHN) following administration through a gastrostomy feeding tube (GT)Joanne W Chiu, Kelvin Chan, Eric X Chen, et al.
Cancer Discovery|April 19, 2014
Promising SINEs for embargoing nuclear-cytoplasmic export as an anticancer strategyDavid S P Tan, Philippe L Bedard, John Kuruvilla, et al.
BMC Cancer|January 21, 2016
Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort studyFernando A Angarita, Amanda J Cannell, Albiruni R Abdul Razak, et al.
Pageof 7